期刊文献+

Ⅲ期乳腺癌综合治疗的前瞻性研究 被引量:3

A randomized prospective study on combined treatment of patients with stage-Ⅲ breast cancer
原文传递
导出
摘要 目的 探讨提高Ⅲ期乳腺癌疗效的方法。方法 前瞻性随机分组 ,85例Ⅲ期乳腺癌患者分为 3组 ,A组 2 8例 (化疗 +手术 +放疗 ) ,放疗后配合辅助化疗 ;B组 2 8例 (手术 +化疗 +放疗 ) ;C组 2 9例 (手术 +放疗 +化疗 )。观察各组的 5年生存率、局部区域复发率和远处转移率差异有无显著性。结果 全部病例 5年生存率为 5 7 6 5 % ,局部区域复发率为 18 82 % ,远处转移率为18 82 %。各组 5年生存率分别为 75 0 0 %、5 3 5 7%、4 4 83% ,A组与C组比较差异有显著性 (P <0 0 5 )。各组局部区域复发率分别为 7 14 %、32 14 %、17 2 4 % ,其中A组与B组比较差异有显著性(P <0 0 5 )。各组远处转移率分别为 7 14 %、10 71%、37 93% ,A组与C组及B组与C组间比较差异均有显著性 (P <0 0 5 )。结论 术前化疗再手术配合术后放疗及辅助化疗可提高Ⅲ期乳腺癌疗效。 Objective To evaluate the curative effect of three different kinds of treatment for patients with stage-Ⅲ breast cancer. Methods Eighty patients with stage-Ⅲ breast cancer were randomized into three different groups:28 were treated by preoperative chemotherapy,combined with surgery and radiotherapy (group A);28 by surgery combined with chemotherapy and radiotherapy (group B);and 29 by surgery combined with radiotherapy and chemotherapy (group C).Differences in local regional recurrence,distant metastasis and 5-year survival rate were analysed for the three groups. Results The five-year survival rates were 57.65%,75.00%,53.57%,44.83% for the whole series and groups A,B,C,respectively.The difference was statistically significant between groups A and C ( P <0.05).The local regional recurrence rates were 18.82%,7.14%,32.14%,17.24% for the whole series and groups A,B,C,respectively.The difference was statistically significant between groups A and B ( P <0.05).The distant metastasis rates were 18.82%,7.14%,10.71%,37.93% for the whole series and groups A,B,C,respectively.The difference was statistically significant between groups A or B and C( P <0.05). Conclusion Preoperative chemotherapy plus surgery and followed by radiotherapy may improve the outcome of stage-Ⅲ breast cancer. ;
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2003年第5期346-348,共3页 Chinese Journal of Radiological Medicine and Protection
关键词 Ⅲ期乳腺癌 综合治疗 前瞻性研究 外科手术 Breast neoplasms Surgery Radiotherapy Chemotherapy
  • 相关文献

参考文献7

  • 1左文述 徐忠法.现代乳腺肿瘤学[M].济南:山东科学技术出版社,1995.155-156.
  • 2张斌,蔡玉娥,张齐,英子伟,蒋书玲,徐宏,郑勇学.局部晚期乳腺癌的综合治疗(附199例分析)[J].中国肿瘤临床,1997,24(2):138-139. 被引量:4
  • 3韩松男 黄今女 崔兴烈.76例Ⅲ期乳腺癌l临床疗效分析[J].中华放射肿瘤学杂志,2000,9:165-166.
  • 4Shen ZZ, Zhang YW, Pan TX. Multidisciplinary approach to the treatment of unresectable breast cancer. World J Surg, 1995,19:843-846.
  • 5Jones AL, Smith IE, O' Brien MER, et al. Phase Ⅱ study of continous infusion fiuorouracil with epirubicin and cisplatin in patient with metastatic and locally advanced breast cancer: an active new regimen. J Clin Oncol, 1994,12:1259-1265.
  • 6Hortabagyi GN, Budar AU. Locally advanced breast cancer:a review including the MD anderson experience. In: Ragaz J, Ariel M, eds. Highrisk breast cancer Ⅱ . Berlin : Springer-Verlag. 1991. 382-385.
  • 7Colais G. Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancer. Int J Rad Oncol Biol, 1993,26:37-41.

共引文献44

同被引文献27

  • 1蔡玉娥,张斌,张齐,英子伟,蒋书玲,郑勇学,徐宏.局部晚期乳腺癌的治疗与预后(附424例临床资料分析)[J].实用肿瘤学杂志,1996,10(2):33-34. 被引量:3
  • 2韩松男,黄今女,崔兴烈.76例Ⅲ期乳腺癌临床疗效分析[J].中华放射肿瘤学杂志,2000,9(3):165.
  • 3[5]Shen ZZ,Zhang YW,Pan TX.Multidisciplinary approach to the treatment of unresectable breast cancer[J].World J Surg,1995;19(6):843-846.
  • 4[6]Jones AL,Smith IE,OBrien MER,et al.Phase Ⅱ study of continous infusion fluorouracil with epirubicin and cisplatin in patient with metastatic and locally advanced breast cancer:An active new regimen[J]. J Clin Oncol,1994;12(6):1259-1265.
  • 5[9]张友会.现代肿瘤学(基础部分)[M].北京:北京医科大学,中国协和医科大学联合出版社,1994:226-229.
  • 6[4]Shen ZZ, Zhang YW, Pan TX. Multidisciplinary approach to the treatment of unresectable breast cancer[J]. WorldJ Surg, 1995, 19(6) :843 ~ 846
  • 7[6]Jones AL, Smith IE, O'Brien MER, et al. Phase Ⅱ study of continous infusion fluorouracil with epirubicin and cisplatin in patient with metastatic and locally advanced breast cancer: an active new regimen[J].J Clin Oncol, 1994, 12(6):1259~1265
  • 8[7]Early Breast Cancer Triallist'Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31,000 recuuence and 24,000 deaths among 75,000 woman[J]. Lancet, 1992, 339 (8784):1 ~15
  • 9左文述.现代乳腺肿瘤学[M].济南:山东科学技术出版社,1995.25-28.
  • 10中国抗癌协会.中国常见恶性肿瘤诊治规范-乳腺癌分册[M].北京:北京医科大学中同协和医科大学联合出版社,1999:45-52.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部